Haemodynamics and structural interventional cardiology - Research unit

Investigator driven observational studies; national and interational randomized clinical trials in patient with acute coronary syndrmomes with particular focus on antithrombotic therapy and in patients undergoing TAVR. 

• Ferlini M. et al. Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry. Catheterization and Cardiovascular Interventions, 2021;
• Ferlini M. et al. Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions, 2019;
• Ferlini M. et al.  Acute coronary syndromes during the first and the second wave of COVID-19. European Journal of Internal Medicine, 2022;
• Ferlini M. et al. Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of Cardiovascular Medicine (Hagerstown), 2021;
• Iannopollo G., Ferlini M. et al. Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI. Journal of the American College of Cardiology, 2017.

Last generation drug eluting stents, current available transcatheter bioprothestic valves, current available transcatheter edge to edge mitral valve repair, current available transcatheter device for PFO/DIA closure, coronary imaging, function coronary stenosis evaluation, short term MCS.

Italian Society of Intervantional Cardiology (GISE).